Efficacy and effect on lipid profiles of Ainuovirine-based regimen versus Efavirenz-based regimen in treatment-naïve people with HIV-1 at week 24: A real-world, retrospective, multi-center cohort study-Reference-Cited by-同舟云学术

Efficacy and effect on lipid profiles of Ainuovirine-based regimen versus Efavirenz-based regimen in treatment-naïve people with HIV-1 at week 24: A real-world, retrospective, multi-center cohort study

Published:2024-04-30 Issue:2 Volume:18 Page:176-186
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Long Hai¹,He Quanying²,Bi Yanmei³,Ke Yingchun⁴,Xie Xiaoxin¹,Zhao Xiuhong³,Tan Si⁵,Luo Yanhe⁶,Chen Zhong⁵,Yu Xiaoli⁶,Li Linghua⁴

Affiliation:

1. Department of Infectious Disease, GuiYang Public Health Clinical Center, Guiyang, Guizhou, China.

2. Department of Outpatient, Yunnan Provincial Infectious Disease Hospital, Kunming, Yunnan, China.

3. Department of Dermatology, Shandong Public Health Clinical Center, Shandong University, Jinan, Shandong, China.

4. Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.

5. Department of Infection and Immunology, The First Hospital of Changsha City, Xiangya School of Medicine of Central South University, Changsha, Hunan, China.

6. Department of Infection and Immunology with Chinese Integrative Medicine, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Link

https://www.jstage.jst.go.jp/article/bst/18/2/18_2024.01070/_pdf

Reference26 articles.

1. 1. Yoshimura K. Current status of HIV/AIDS in the ART era. J Infect Chemother. 2017; 23:12-16.

2. 2. Wang N, Lan G, Zhu Q, et al. HIV Epidemiology, Care, and Treatment Outcomes Among Student and Nonstudent Youths Living With HIV in Southwest China Between 1996 and 2019: Historical Cohort Study. JMIR Public Health Surveill. 2023; 9:e38881.

3. 3. Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017; 28:636-650.

4. 4. Naghavi M. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. Bmj. 2019; 364:l94.

5. 5. Cha YJ, Lim KS, Park MK, Schneider S, Bray B, Kang MC, Chung JY, Yoon SH, Cho JY, Yu KS. Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects. Drug Des Devel Ther. 2014; 8:1613-1619.